These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1689941)

  • 1. Evaluation of a sensitive immunoenzymetric assay for maternal-serum alpha-fetoprotein screening. Comparison with radioimmunoassay.
    Bock JL
    Am J Clin Pathol; 1990 Mar; 93(3):352-6. PubMed ID: 1689941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal serum screening for neural tube defects and Down's syndrome.
    Robertson EF
    Med J Aust; 1991 Jul; 155(2):67-8. PubMed ID: 1713290
    [No Abstract]   [Full Text] [Related]  

  • 3. Assay precision of serum alpha fetoprotein in antenatal screening for neural tube defects and Down's syndrome.
    Wald NJ; Hackshaw AK; George LM
    J Med Screen; 2000; 7(2):74-7. PubMed ID: 11002446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18.
    Akbas SH; Ozben T; Alper O; Ugur A; Yücel G; Lüleci G
    Clin Chem Lab Med; 2001 Jun; 39(6):487-90. PubMed ID: 11506458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-justification analysis of prenatal maternal serum alpha-feto protein screening.
    Taplin SH; Thompson RS; Conrad DA
    Med Care; 1988 Dec; 26(12):1185-202. PubMed ID: 2462141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual analyte immunoassay in neural tube defect and Down's syndrome screening: results of a multicentre clinical trial.
    Spencer K; Macri JN; Anderson RW; Aitken DA; Berry E; Crossley JA; Wood PJ; Coombes EJ; Stroud M; Worthington DJ
    Ann Clin Biochem; 1993 Jul; 30 ( Pt 4)():394-401. PubMed ID: 7691041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of normal MSAFP screening on maternal age for genetic amniocentesis.
    Ganiats TG; Berry CC; Fullerton JT
    J Clin Epidemiol; 1990; 43(11):1143-8. PubMed ID: 1700812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local norms of maternal serum alpha-fetoprotein values in early second trimester: a prelude to a Down's syndrome screening programme incorporating maternal serum alpha-fetoprotein values.
    Lai FM; Yeo SH; Yo SL; Tan IK
    Singapore Med J; 1991 Apr; 32(2):134-7. PubMed ID: 1710394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-fetoprotein: an enhanced-sensitivity assay for neural tube defect and Down syndrome evaluation.
    Musto JD; Pizzolante JM; Chesarone VP; Sassi AM; Sane R
    Clin Chem; 1986 Jul; 32(7):1412. PubMed ID: 2424639
    [No Abstract]   [Full Text] [Related]  

  • 11. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ; Kennard A
    Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum screening.
    Carroll JC
    Can Fam Physician; 1994 Oct; 40():1756-64. PubMed ID: 7524838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Down's syndrome and neural tube defect in Croatia. A regional prospective study.
    Brajenović-Milić B; Tislarić D; Bacić J; Paravić J; Slivar AE; Kapovic M; Kosec V; Ristic S; Rajhvajn B
    Fetal Diagn Ther; 1998; 13(6):367-71. PubMed ID: 9933821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Down's syndrome using serum alpha fetoprotein: a retrospective study indicating caution.
    Spencer K; Carpenter P
    Br Med J (Clin Res Ed); 1985 Jun; 290(6486):1940-3. PubMed ID: 2408699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved reliability of a serum alpha-fetoprotein enzyme immunoassay compared with a radioimmunoassay.
    Peleg L; Slor H; Cordova T; Ayalon D; Legum C; Rudick A
    Isr J Med Sci; 1986; 22(3-4):215-9. PubMed ID: 2427476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of maternal serum alpha fetoprotein with a Polish AFP radioimmunoassay--a suitable screening method for neural tube defects?].
    Schlosser H; Greiff R
    Zentralbl Gynakol; 1986; 108(15):914-8. PubMed ID: 2429479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How women cope with the results of maternal serum screening for fetal neural tube defects and Down syndrome].
    Kamerbeek LI; Roelofsen EE; Beekhuis JR; Tijmstra T; Mantingh A
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1308-11. PubMed ID: 7688449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.
    Spencer K; Coombes EJ; Mallard AS; Ward AM
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():506-18. PubMed ID: 1280026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Analyte immunoassay--a new approach to neural tube defect and Down's syndrome screening.
    Macri JN; Spencer K; Anderson R
    Ann Clin Biochem; 1992 Jul; 29 ( Pt 4)():390-6. PubMed ID: 1379420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.